老年人初级和二级预防的他类药物治疗
1Department of Cardiology, Jefferson University Hospital, Sidney Kimmel Medical College, 227 North Broad Street, Suite 200, Philadelphia, PA, 19107, USA.
Current atherosclerosis reports
|November 25, 2024
概括
立方体治疗有效地减少了老年人的心血管事件. 年龄不是障碍;个性化讨论应该指导初级和二级预防的他类药物决定.
科学领域:
- 心脏病学 心脏病学
- 老年医学 老年医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 立方体治疗已被证明可以预防40-75岁的成年人的动脉样硬化心血管疾病 (ASCVD).
- 关于他类药物对老年人的益处的证据仍然不太清楚.
研究的目的:
- 审查关于老年患者使用他类药物的现有证据.
- 总结了老年人初级和二级ASCVD预防的指南.
主要方法:
- 对现有研究和临床指南的文献综述.
- 对老年人群中他类药物的疗效和安全性数据的分析.
主要成果:
- 中度至高强度的他类药物治疗可以降低老年患者心血管事件的发生率.
- 心脏生物标志物和冠状动脉评分可以识别高风险的老年人.
- 仅仅是年龄不应该阻止开始使用他类药物治疗.
结论:
- 类固醇药物治疗对老年人心血管风险降低有好处.
- 患者与临床医生的讨论至关重要,考虑到ASCVD的整体风险,预期寿命和生活质量.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
536
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
536
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
150
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
150
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
129
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
129
Alzheimer's Disease: Treatment
165
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
165
Antihypertensive Drugs: Direct Renin Inhibitors
493
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
493
Rheumatic Heart Disease III: Medical Management
3
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
3


